Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpiFix for Pyoderma Gangrenosum
NCT05120726Phase 4Terminated
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Jun 2021
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in pyoderma gangrenosum (PG), sponsored by Louisiana State University Health Sciences Center. Primary endpoints: Gene Measurements at 2 weeks and Wound Size at 6 months. Started Jun 2021; status: terminated.
02
Conditions
pyoderma gangrenosum (PG)
Beyond the preview
Go deeper on NCT05120726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05120726.